Christian Medical College, Vellore, widely known as CMC, Vellore, is a private, Christian community-run medical school, hospital and research institute. This Institute includes a network of primary, secondary and tertiary care hospitals in and around Vellore, Tamil Nadu, India.

During the past decade, Christian Medical College conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 17 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 11 clinical trials were completed. i.e. 42.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christian Medical College" #1 sponsor was "Christian Medical College, Vellore, India" with 8 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christian Medical College" #1 collaborator was "Christian Medical College, Vellore, India" with 15 trials as a collaborator, "Kamuzu University of Health Sciences" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Foundation for Innovative New Diagnostics, Switzerland" with 2 trials as a collaborator and "Imperial College London" with 2 trials as a collaborator. Other collaborators include 86 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Christian Medical College" are "Breast Cancer" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Diarrhea" (2 trials), "Hemophilia A" (2 trials) and "Hemophilia B" (2 trials). Many other conditions were trialed in "Christian Medical College" in a lesser frequency.

Most popular intervention types in "Christian Medical College" are "Drug" (43 trials), "Biological" (17 trials), "Other" (12 trials), "Device" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Baricitinib" (3 trials), "Docetaxel" (3 trials), "Actos" (2 trials) and "MBX-102" (2 trials). Other intervention names were less common.

The vast majority of trials in "Christian Medical College" are 70 trials for "All" genders, 8 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Christian Medical College". 1 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Christian Medical College, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Christian Medical College, 8 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 6 trials that are defined as “Not Applicable".

Christian Medical College has several departments that took part in Clinical trials: "Christian Medical College, Department of Medical Oncology" - 2 trials